Dawn Faller/Linkedin
Apr 24, 2026, 17:35
Dawn Faller: Strengthening Global Collaboration in Apheresis at the 2026 ASFA and WAA Joint Meeting
Dawn Faller, Sr. Manager of Global Clinical Marketing at Terumo Blood and Cell Technologies, shared a post on LinkedIn:
”Today we had the opportunity to welcome attendees of the 2026 ASFA and WAA Joint Meeting to the Terumo Blood and Cell Technologies Campus Headquarters ahead of the meeting kickoff.
This tour was a great opportunity to showcase the people and technologies behind our work.
It also highlighted how our teams at Terumo Blood and Cell Technologies are working alongside partners across the field to advance apheresis and help ensure blood remains an essential therapy for patients worldwide.
Looking forward to continuing these conversations throughout the conference.”
Stay updated with Hemostasis Today.
-
May 6, 2026, 18:03Shiv Choudhary: Did You Know That Varicose Veins Can Be Detected with a Simple Test?
-
May 6, 2026, 17:48A Hidden Mechanical Cause of Recurrent Thrombosis in a Young Athlete – The Lancet
-
May 6, 2026, 17:26Joanna Fraser: Highlights from WFH Congress 2026 in Malaysia
-
May 6, 2026, 17:04Nour Al-Mozain: Massive Transfusion in Pediatrics
-
May 6, 2026, 16:36Ney Carter Borges: Randomized Trial of the Vascular Effects of Low-Dose Colchicine in High-Risk Type 2 Diabetes
-
May 6, 2026, 16:35Giuseppe Lippi: Essential Laboratory Testing in Emergencies
-
May 6, 2026, 16:28Anna-Maria Tsilia: Addressing Psychological Aspects of Hemophilia at WFH 2026
-
May 6, 2026, 16:24Elena Donoso Úbeda: Attending WFH 2026 for Manual Therapy Workshop and Global Collaboration
-
May 6, 2026, 16:22Dhamirah Nazihah Mohd Nasiruddin: Reflecting on a Transformative Fellowship in Haemostasis and Thrombosis at Barts Health